← Back
$ORMP All transactions

ORAMED PHARMACEUTICALS INC.

A

$ Value

$0

Shares

115,000

Price

$0

Filed

Jan 2

Insider

Name

Gabay Avraham

Title

Chief Financial Officer

CIK

0001777328

Roles

Officer

Transaction Details

Transaction Date

2025-12-31

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

630,256

Footnotes

Represents Restricted Stock Units ("RSUs") that vested in full on January 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer. | Represents RSUs that will vest in quarterly installments over a three-year period starting January 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer. | Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. The PSUs vest upon the achievement of either (i) the Issuer's Common Stock achieving a specified price per share, or (ii) the achievement of the applicable performance criteria.

Filing Info

Accession No.

0001213900-26-000658

Form Type

4

Issuer CIK

0001176309

Gabay Avraham's History

Date Ticker Type Value
2026-03-17 ORMP A $0
2026-01-22 ORMP M $0
2026-01-22 ORMP M $0
2025-12-31 ORMP A $0
2025-12-31 ORMP A $0
2025-12-31 ORMP A $0

Other Insiders at ORMP (90d)

Insider Bought Sold Last
KIDRON NADAV
President and CEO
2026-03-30
Kidron Miriam
Chief Scientific Officer
2026-03-30
Hexter Joshua
COO & CBO
2026-03-17
Gabay Avraham
Chief Financial Officer
2026-03-17